Literature DB >> 6422578

Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis.

J Efthimiou, M E Hodson, P Taylor, A G Taylor, J C Batten.   

Abstract

From January to April 1980 46 young adults with cystic fibrosis were studied for evidence of infection with a wide variety of microorganisms, including viruses and Legionella pneumophila. Two groups of patients were investigated: a "deteriorated" group of 24 patients who had experienced an increase in lower respiratory tract symptoms and fall in lung function values in the course of one month before the start of the study and a "stable" group of 22 patients with no such deterioration. All serological tests were repeated at one month and then one year after the beginning of the study. A fourfold rise in titres of antibodies to various viruses, Mycoplasma pneumoniae, and Coxiella burnetii was obtained in seven (29%) of the deteriorated group but in only one (4.5%) of the stable group (p less than 0.05). One other patient showed a fourfold rise in L pneumophila antibody titre (on the basis of the indirect fluorescent antibody test), which was accompanied by a respiratory illness consistent with legionnaires' disease. Eight of the 46 patients (17.4%) had demonstrable titres of antibody against L pneumophila (1/32 or above).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422578      PMCID: PMC459743          DOI: 10.1136/thx.39.2.150

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  The pulmonary manifestations of fibrocystic disease of the pancreas.

Authors:  P A DI SANT'AGNESE
Journal:  Dis Chest       Date:  1955-06

2.  The flora of the respiratory tract of patients with cystic fibrosis of the pancreas.

Authors:  N N HUANG; E L VAN LOON; K T SHENG
Journal:  J Pediatr       Date:  1961-10       Impact factor: 4.406

3.  Cystic fibrosis of the pancreas.

Authors:  D H ANDERSEN
Journal:  J Chronic Dis       Date:  1958-01

4.  Serological differentiation of Legionnaires' Disease and Mycoplasma pneumoniae pneumonia.

Authors:  A G Taylor; T G Harrison; B E Andrews; M Sillis
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

5.  Severe mycoplasma pneumonia.

Authors:  S Holt; W F Ryan; E J Epstein
Journal:  Thorax       Date:  1977-02       Impact factor: 9.139

6.  Legionnaires' disease. Postmortem pathologic findings of 20 cases.

Authors:  F J Hernandez; B D Kirby; T M Stanley; P H Edelstein
Journal:  Am J Clin Pathol       Date:  1980-04       Impact factor: 2.493

7.  Diagnosis of Legionella pneumophila infections by means of formolised yolk sac antigens.

Authors:  T G Harrison; A G Taylor
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

8.  False positive reactions in the indirect fluorescent antibody test for Legionnaires' disease eliminated by use of formolised yolk-sac antigen.

Authors:  A G Taylor; T G Harrison; M W Dighero; C M Bradstreet
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

9.  Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis.

Authors:  P F Wright; K T Khaw; M N Oxman; H Shwachman
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

10.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

View more
  19 in total

1.  Viral infections: a role in the lung disease of cystic fibrosis?

Authors:  D J Shale
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

Review 2.  Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Authors:  Karen A Robinson; Olaide A Odelola; Ian J Saldanha
Journal:  Cochrane Database Syst Rev       Date:  2016-07-20

3.  Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms.

Authors:  E L Ong; M E Ellis; A K Webb; K R Neal; M Dodd; E O Caul; S Burgess
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

Review 4.  Managing adults with cystic fibrosis.

Authors:  M E Hodson
Journal:  BMJ       Date:  1989-02-25

Review 5.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

Authors:  S P Conway; E J Simmonds; J M Littlewood
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

7.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

Authors:  H K Johansen; N Høiby
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

Review 8.  The impact of respiratory viral infections in patients with cystic fibrosis.

Authors:  C G Prober
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 9.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 10.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.